Private limited company · founded 2023 · 3 yrs activeLeuvensesteenweg 246, 1932 Zaventem, BelgiumKBO/BCE: BE 0800.487.154
Summary
NAS CARE has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals. The 2023 annual accounts show equity of €14,751 and a net result of €10,751. Its solvency ranks better than 38% of 17927 sector peers (fiscal year 2023). The computed 12-month bankruptcy probability is 1.0% (low).
Signals- Figures for FY 2023 (filed 31-07-2024)- 2 financial years not filed after the legal deadline+ Sector Human health activities (NACE 86)+ Liquidity: current ratio 2.15, cash €17,815Latest accounts filed on timeShow the evidence
Checked score
No current score
Checked score
A figure from 0 to 100 for financial health from the latest annual accounts: the higher, the healthier. Without a figure, the card says why. A low score is a reason to look closely at payment terms and security.
Figures too old
The available figures for FY 2023 are too old to assess current financial health.
Financial strength, FY 2023
Financial strength
How strong the balance sheet and results are, apart from the score: solvency, liquidity and profitability from the latest accounts, each out of 100. The score itself is the bankruptcy probability.
Strong
Solvency79
equity 53.8% of total assets
Liquidity77
short-term debt 46.2% · cash 65.0%
Profitability100
return on assets 39.2%
Bankruptcy probability, 12 months
Bankruptcy probability
The chance that this company goes bankrupt within twelve months. A low chance is reassuring; with a higher one, agree shorter payment terms or an advance.
1.0%Low
0%0.5%1.5%4%10%≥ 25%
About 1 in 100 comparable companies go bankrupt within 12 months (an estimate).
Sector median < 0.1% (23,682 companies)
Last 24 months11-2024: < 0.1%lowest value12-2024: < 0.1%● 0.0% vs 11-2024lowest value01-2025: < 0.1%● 0.0% vs 12-2024lowest value02-2025: < 0.1%● 0.0% vs 01-2025lowest value03-2025: < 0.1%▲ +10.0% vs 02-202504-2025: < 0.1%▲ +6.1% vs 03-202505-2025: < 0.1%▲ +11.4% vs 04-202506-2025: < 0.1%● 0.0% vs 05-202507-2025: < 0.1%▲ +10.3% vs 06-202508-2025: 0.1%▲ +60.5% vs 07-202509-2025: 0.1%▲ +36.2% vs 08-202510-2025: 0.2%▲ +124% vs 09-202511-2025: 0.2%▲ +8.1% vs 10-202512-2025: 0.3%▲ +30.7% vs 11-202501-2026: 0.5%▲ +66.1% vs 12-202502-2026: 0.5%● 0.0% vs 01-202603-2026: 0.5%▲ +6.9% vs 02-202604-2026: 0.5%▼ -12.1% vs 03-202605-2026: 0.5%● 0.0% vs 04-202606-2026: 0.5%▼ -2.2% vs 05-202607-2026: 0.5%▲ +1.1% vs 06-202608-2026: 1.0%▲ +122% vs 07-2026highest value09-2026: 1.0%● 0.0% vs 08-2026highest value10-2026: 1.0%▼ -3.6% vs 09-2026
Figures for FY 2023 (filed 31-07-2024)raises the probability
Sector Human health activities (NACE 86)lowers the probability
2 financial years not filed after the legal deadlineraises the probability
Liquidity: current ratio 2.15, cash €17,815lowers the probability
tick = median of all Belgian filingsring = median in the sector
This company filed its 2023 accounts on the deadline day; the sector median for financial year 2023 is 5 days before the deadline, and 39% of the sector filed late.
Checked, nothing found (1)
○
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage
Annual accounts filedfiscal year 2023 · micro…
Key points
Caution: Among the weakest 12% on equitysector median €149,175 · 17,932 companies€14,751View
Total assets 2023first fiscal year filed€27,428View